Salidroside Alleviates Methamphetamine-Induced Cognitive Impairment by Targeting the AKT Pathway to Reduce Neuronal Apoptosis and Neuroinflammation
Neuropharmacology and Therapy · 2025
DOI: 10.15212/npt-2025-0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropharmacology and Therapy, 2025. Verfasst von Xu Zhao und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Methamphetamine (METH) abuse causes cognitive impairment via neuronal apoptosis, inflammation, and oxidative stress. Salidroside (Sal), a natural compound with anti-apoptotic and anti-inflammatory properties, may offer neuroprotection. This study evaluated the effects of Sal on METH-induced cognitive impairment and the underlying mechanisms. C57BL/6 mice were divided into control, METH, and METH + Sal groups. Behavioral tests (Novel Object Recognition and Y-maze) assessed cognitive function. Neuronal apoptosis and microglial activation were examined by TUNEL staining and Iba-1 immunofluorescence. Western blotting detected cleaved-caspase 3, cleaved-PARP, IL-6, IL-1β, and components of the Nrf2-HO-1, NF-κB, and AKT pathways. Oxidative stress markers (total antioxidant capacity [T-AOC], superoxide dismutase [SOD], and malondialdehyde [MDA]) were measured using an enzyme-linked immunosorbent assay (ELISA). Network pharmacology and protein-protein interaction (PPI) analysis identified AKT as a key Sal target, which was validated using the AKT inhibitor, MK-2206. Sal significantly improved cognitive performance, reduced neuronal apoptosis, suppressed microglial activation, and alleviated oxidative stress. Mechanistically, Sal activated the AKT pathway, which mediated the neuroprotective effects. These results suggest that Sal mitigates METH-induced cognitive dysfunction by targeting AKT to inhibit apoptosis, inflammation, and oxidative damage. This study highlights the potential of Sal as a therapeutic candidate for neurodegenerative diseases associated with stimulant-induced neurotoxicity.
Zitieren
APA
Zhao, X., Zhang, J., Qiu, F., Cai, C., Zhang, Y., Wang, H., Chen, C., & Lu, J. (2025). Salidroside Alleviates Methamphetamine-Induced Cognitive Impairment by Targeting the AKT Pathway to Reduce Neuronal Apoptosis and Neuroinflammation. Neuropharmacology and Therapy. https://doi.org/10.15212/npt-2025-0003
Vancouver
Zhao X, Zhang J, Qiu F, Cai C, Zhang Y, Wang H, et al. Salidroside Alleviates Methamphetamine-Induced Cognitive Impairment by Targeting the AKT Pathway to Reduce Neuronal Apoptosis and Neuroinflammation. Neuropharmacology and Therapy. 2025. doi:10.15212/npt-2025-0003
BibTeX
@article{Zhao2025,
author = {Zhao, Xu and Zhang, Jingyi and Qiu, Feng and Cai, Cheng and Zhang, Yining and Wang, Huijun and Chen, Chuanxiang and Lu, Jiancong},
title = {Salidroside Alleviates Methamphetamine-Induced Cognitive Impairment by Targeting the AKT Pathway to Reduce Neuronal Apoptosis and Neuroinflammation},
journal = {Neuropharmacology and Therapy},
year = {2025},
doi = {10.15212/npt-2025-0003}
}
EUVIMED